[Prophylactic treatment in children with migraine presenting changes in electrophysiological and cerebral blood flow

J Biernawska1, K Miller, K Pierzchała

  • 1II Katedra i Klinika Neurologii SAM w Zabrzu.

Insights

Prophylactic antimigrainous treatment improved clinical symptoms and brain activity in children with migraine. This study highlights the effectiveness of combined treatments for pediatric migraine, impacting both symptoms and EEG findings.

Area of Science:

  • Pediatric Neurology
  • Neurophysiology
  • Clinical Trials

Context:

  • Idiopathic headache and migraine are prevalent in children, posing diagnostic and therapeutic challenges due to a lack of specific tests.
  • Electroencephalogram (EEG) abnormalities, specifically paroxysmal changes, have been observed in some pediatric migraine patients.

Purpose:

  • To investigate the impact of prophylactic antimigrainous treatment on the clinical presentation and electroencephalographic (EEG) activity in children with migraine.
  • To assess the efficacy of combined therapeutic approaches in managing pediatric migraine.

Summary:

  • The study involved 50 children (aged 6-18) diagnosed with migraine. Routine EEG, ECG, and cerebral blood flow (CBF) were assessed. Fifteen patients with paroxysmal EEG changes received a 6-month prophylactic treatment (Hydacorn or Sermion).
  • All treated children showed clinical improvement. While paroxysmal EEG changes persisted in some, the overall results demonstrated the clinical effectiveness of the prophylactic treatment and its positive influence on bioelectrical brain activity.

Impact:

  • The findings suggest a potential link between migraine, epilepsy, and cerebral blood flow disturbances (angiospasm/hypoxia) in children.
  • This research underscores the clinical efficacy of combined treatment strategies for pediatric migraine, positively affecting both clinical outcomes and neurophysiological markers.

Related Concept Videos